Vision

A WORLD WHERE EVERY PERSON WITH DOWN SYNDROME THRIVES WITH IMPROVED HEALTH, INDEPENDENCE, AND OPPORTUNITIES TO REACH THEIR FULLEST POTENTIAL.

Mission
We accelerate research to increase availability of therapeutic, diagnostic, and medical care options and
we empower families through education, connections, and support.

Your Donation Helps

Down syndrome research offers opportunities for people of all ages with Down syndrome. Your support is essential to finding safe, effective drugs and interventions to improve health and independence. We empower families through education, connections and support. Your gift is crucial to furthering these breakthroughs.

We’ve designed a clear path to therapies

Based on recent scientific findings, our CEO, board and world renowned scientific advisors have established four priorities for funding research. We’re focused on exciting research targeting the root cause with the objective of improving health and independence for our loved ones throughout their lifetimes. Our four priorities are: preventing Alzheimer’s onset, improving cognition, developing gene therapies, and advancing understanding.

LuMind RDS News

National non-profits, LuMind RDS and IDSC, merge to provide improved health, independence and opportunities for children and adults with Down syndrome.

March 21, 2019 3:21 p.m. EST Burlington, Mass. – As millions all over the world celebrate World Down Syndrome Day on March 21, two non-profit organizations are taking it one step further. LuMind Research Down Syndrome Foundation (LuMind RDS) and the International Down Syndrome Community (IDSC) announced today that they have combined operations, effectively merging …

Read More

What people are saying about us.

“I never thought I would be in a position to say, ‘We are going to take therapies forward to directly treat Down syndrome.’ Now I think that is the case. We really are in the early stages of a revolution in understanding the basis for many of the features that occur in Down syndrome.”

Dr. Roger Reeves, Johns Hopkins